Find More Contacts for Octant Bio
Protected Content
Manager Operations
1 email found
View contacts for Octant Bio to access new leads and connect with decision-makers.
View All Contacts
  • Company Type For Profit

Octant Bio is a developer of synthetic technology used to improve health and treat disease. Its technology uses synthetic biology, genome engineering, next-generation sequencing, and computational tools to simultaneously measure the activity of thousands of receptor pathways in human cells that enable scientists to apply machine learning methods to

engineer small molecules that interact with multiple receptors and unlock a new potential to treat complex diseases.

Lists Featuring This Company

Biotechnology Early Stage Companies With Less Than $500M in Revenue
1,788 Number of Organizations â€¢ $77.1B Total Funding Amount â€¢ 10,724 Number of Investors
Biotechnology Early Stage Companies With Less Than $50M in Revenue
1,770 Number of Organizations â€¢ $76.2B Total Funding Amount â€¢ 10,626 Number of Investors
United States Early Stage Companies With More Than $1M in Revenue
7,197 Number of Organizations â€¢ $240.4B Total Funding Amount â€¢ 50,943 Number of Investors
United States Early Stage Companies With More Than 50 Employees
2,942 Number of Organizations â€¢ $161.3B Total Funding Amount â€¢ 23,856 Number of Investors

Frequently Asked Questions

Where is Octant Bio's headquarters? Octant Bio is located in Los Angeles, California, United States.Who invested in Octant Bio? Octant Bio has 18 investors including What If Ventures and Allen & Company.How much funding has Octant Bio raised to date? Octant Bio has raised .When was the last funding round for Octant Bio? Octant Bio closed its last funding round on Apr 28, 2022 from a Series B round.Who are Octant Bio's competitors? Alternatives and possible competitors to Octant Bio may include ONICerevance, and Kytopen.